Google AI
The Times Australia
The Times World News

.

A drug that can extend your life by 25%? Don’t hold your breath

  • Written by Hassan Vally, Associate Professor, Epidemiology, Deakin University

Every few weeks or months, the media reports on a new study that tantalisingly dangles the possibility of a new drug to give us longer, healthier lives.

The latest study[1] centres around a drug involved in targeting interleukin-11, a protein involved in inflammation. Blocking this protein appeared to help mice stave off disease and extend their life by more than 20%.

If only defying the ravages of time could be achieved through such a simple and effort-free way – by taking a pill. But as is so often the case, the real-world significance of these findings falls a fair way short of the hype.

The role of inflammation in disease and ageing

Chronic inflammation in the body plays a role in causing disease and accelerating ageing. In fact, a relatively new label has been coined[2] to represent this: “inflammaging”.

While acute inflammation is an important response to infection or injury, if inflammation persists in the body, it can be very damaging.

A number of lifestyle, environmental and societal drivers contribute to chronic inflammation in the modern world. These are largely the factors we already know are associated with disease and ageing[3], including poor diet, lack of exercise, obesity, stress, lack of sleep, lack of social connection and pollution.

While addressing these issues directly is one of the keys to addressing chronic inflammation, disease and ageing, there are a number of research groups also exploring how to treat chronic inflammation with pharmaceuticals. Their goal is to target and modify the molecular and chemical pathways involved in the inflammatory process itself.

What the latest research shows

This new interleukin-11 research[4] was conducted in mice and involved a number of separate components.

In one component of this research, interleukin-11 was genetically knocked out in mice. This means the gene for this chemical mediator was removed from these mice, resulting in the mice no longer being able to produce this mediator at all.

In this part of the study, the mice’s lives were extended by over 20%, on average.

Another component of this research involved treating older mice with a drug that blocks interleukin-11.

Injecting this drug into 75-week old mice (equivalent to 55-year-old humans) was found to extend the life of mice by 22-25%.

These treated mice were less likely to get cancer and had lower cholesterol levels, lower body weight and improved muscle strength and metabolism.

From these combined results, the authors concluded, quite reasonably, that blocking interleukin-11 may potentially be a key to mitigating age-related health effects and improving lifespan in both mice and humans.

Why you shouldn’t be getting excited just yet

There are several reasons to be cautious of these findings.

First and most importantly, this was a study in mice. It may be stating the obvious, but mice are very different to humans. As such, this finding in a mouse model is a long way down the evidence hierarchy in terms of its weight.

Research shows only about 5%[5] of promising findings in animals carry over to humans. Put another way, approximately 95% of promising findings in animals may not be translated to specific therapies for humans.

Second, this is only one study. Ideally, we would be looking to have these findings confirmed by other researchers before even considering moving on to the next stage in the knowledge discovery process and examining whether these findings may be true for humans.

We generally require a larger body of evidence before we get too excited about any new research findings and even consider the possibility of human trials.

Third, even if everything remains positive and follow-up studies support the findings of this current study, it can take decades for a new finding like this to be translated to successful therapies in humans.

Until then, we can focus on doing the things we already know make a huge difference to health and longevity: eating well, exercising, maintaining a healthy weight, reducing stress and nurturing social relationships.

References

  1. ^ latest study (www.nature.com)
  2. ^ been coined (pubmed.ncbi.nlm.nih.gov)
  3. ^ associated with disease and ageing (theconversation.com)
  4. ^ new interleukin-11 research (www.nature.com)
  5. ^ only about 5% (theconversation.com)

Read more https://theconversation.com/a-drug-that-can-extend-your-life-by-25-dont-hold-your-breath-235313

Times Magazine

Why Is Professional Porsche Servicing Important for Performance and Longevity?

Owning a Porsche is a symbol of precision engineering, luxury, and high performance. To maintain t...

6 ways your smartwatch is lying to you, according to science

You check your smartwatch after a run. Your fitness score has dropped. You’ve burnt hardly any...

Has the adoption of electric vehicles led to new forms of electricity theft

Why the concern exists Electric vehicles (EVs) like the Tesla Model 3 or Nissan Leaf shift “fue...

Adobe Ushers in a New Era of Creativity with New Creative Agent and Generative AI Innovations in Adobe Firefly

Adobe (Nasdaq: ADBE) — the global technology leader that unleashes creativity, productivity and ...

CRO Tech Stack: A Technical Guide to Conversion Rate Optimization Tools

The fascinating thing is that the value of this website lies in the fact that creating a high-cali...

How Decentralised Applications Are Reshaping Enterprise Software in Australia

Australian businesses are experiencing a quiet revolution in how they manage data, execute agreeme...

The Times Features

Power Bills: What Are the Options to Decrease What a Fa…

Australian households are being told, repeatedly, to “use less power.” Turn off lights. Shorten...

The Times Launches Dedicated Property Advertising Platf…

In a significant expansion of its digital media offering, The Times has formally launched TimesA...

Can I get a free flu shot? And will it cover ‘super K’?…

For many of us, flu can mean a nasty few weeks of illness. But for the very young and old, and...

Mother’s Day, The Lodge Dining Room

Her Day, The Lodge Way This Mother’s Day, The Lodge Dining Room presents a refined take on high...

The Albanese Government’s plan to impose a retrospectiv…

LABOR’S RETROSPECTIVE TAX GRAB RISKS 3 MILLION JOBS The Albanese Government’s plan to impose a retr...

Court outcome reinforces wildlife trafficking will not …

A 20-year-old man has been fined close to $50,000 and ordered to pay costs after pleading guilty t...

Businesses tap UOW PhD researchers to accelerate innova…

Industry internship program connects businesses with research talent to fast-track innovation an...

Olivia Colman, Kate Box to join an exclusive Live Q…

Photo credit : Photo Credit Mark De BlokFresh out of cinemas, JIMPA - the new film by acclaimed di...

Rental growth reaccelerates as cost to tenants reaches …

Australian renters are spending a record share of their gross median household income on housing c...